Biovet, a part of Bharat Biotech, has received approval to market Biolumpvaxin, a groundbreaking DIVA marker vaccine for lumpy skin disease in cattle and buffaloes. The launch of this vaccine marks a ...

Animal health vaccine maker Biovet, a Bharat Biotech group firm, announced on Monday that it has received approval from the Central Drug Standards Control Organization (CDSCO) for its lumpy skin ...

WINDHOEK, Feb. 14 (Xinhua) -- Namibia's Directorate of Veterinary Services (DVS) has updated control measures to combat the ongoing outbreak of Lumpy Skin Disease (LSD) affecting cattle across ...

Bharat Biotech group company, Biovet, has received approval from the national drugs regulator to market a vaccine against lumpy skin disease (LSD) in dairy cattle and buffaloes, the company ...

licence for the lumpy skin disease (LSD) vaccine for dairy cattle and buffaloes Biolumpivaxin it developed in collaboration with Indian Council of Agriculture Research (ICAR). As the first ...

The EMA's human medicines committee (CHMP ... to treat adults with moderate to severe PN, a disease which causes hard lumps to form on the skin that are so itchy they can lead patients to scratch ...

Biovet, a part of Bharat Biotech, on Monday said it has received approval from the Central Drug Standards Control Organisation (CDSCO) to market a vaccine for lumpy skin disease (LSD) in dairy ...

Also Read: Bharat Biotech collaborates with US-based Alopexx to develop antimicrobial vaccine Lumpy skin disease is a transboundary animal disease that has gained significant attention in India ...